Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.

Gianella S, Kosakovsky Pond SL, Oliveira MF, Scheffler K, Strain MC, De la Torre A, Letendre S, Smith DM, Ellis RJ.

Virus Evol. 2016 Aug 3;2(2):vew020.

2.

Envelope gene evolution and HIV-1 neuropathogenesis.

Vázquez-Santiago FJ, Rivera-Amill V.

J Neuroinfect Dis. 2015 Oct;6(Suppl 2). pii: 003.

3.

Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission.

Sanborn KB, Somasundaran M, Luzuriaga K, Leitner T.

Retrovirology. 2015 Nov 16;12:96. doi: 10.1186/s12977-015-0222-0.

4.

Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment.

Vázquez-Santiago F, García Y, Rivera-Román I, Noel RJ Jr, Wojna V, Meléndez LM, Rivera-Amill V.

J Virol Antivir Res. 2015;4(1). doi: 10.4172/2324-8955.1000135.

5.

Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.

Peters PJ, Gonzalez-Perez MP, Musich T, Moore Simas TA, Lin R, Morse AN, Shattock RJ, Derdeyn CA, Clapham PR.

Retrovirology. 2015 Jun 9;12:48. doi: 10.1186/s12977-015-0176-2.

6.
7.

Viral diseases of the central nervous system.

Swanson PA 2nd, McGavern DB.

Curr Opin Virol. 2015 Apr;11:44-54. doi: 10.1016/j.coviro.2014.12.009. Review.

8.

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.

Lacek K, Urbanowicz RA, Troise F, De Lorenzo C, Severino V, Di Maro A, Tarr AW, Ferrara F, Ploss A, Temperton N, Ball JK, Nicosia A, Cortese R, Pessi A.

J Biol Chem. 2014 Dec 12;289(50):35015-28. doi: 10.1074/jbc.M114.591826.

9.

Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.

Zhuang K, Leda AR, Tsai L, Knight H, Harbison C, Gettie A, Blanchard J, Westmoreland S, Cheng-Mayer C.

J Virol. 2014 Aug;88(15):8407-20. doi: 10.1128/JVI.01237-14.

10.
11.

Identifying recombination hot spots in the HIV-1 genome.

Smyth RP, Schlub TE, Grimm AJ, Waugh C, Ellenberg P, Chopra A, Mallal S, Cromer D, Mak J, Davenport MP.

J Virol. 2014 Mar;88(5):2891-902. doi: 10.1128/JVI.03014-13.

12.

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Zapata JC, Goicochea M, Nadai Y, Eyzaguirre LM, Carr JK, Tallon LJ, Sadzewicz L, Myers G, Fraser CM, Su Q, Djavani M, Lukashevich IS, Salvato MS.

J Virol. 2014 Mar;88(6):3058-66. doi: 10.1128/JVI.03035-13.

13.

Frequent intra-subtype recombination among HIV-1 circulating in Tanzania.

Kiwelu IE, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, Shao J, McLane MF, Kapiga SH, Essex M.

PLoS One. 2013 Aug 5;8(8):e71131. doi: 10.1371/journal.pone.0071131.

14.

The emergence of drug resistant HIV variants and novel anti-retroviral therapy.

Paydary K, Khaghani P, Emamzadeh-Fard S, Alinaghi SA, Baesi K.

Asian Pac J Trop Biomed. 2013 Jul;3(7):515-22. doi: 10.1016/S2221-1691(13)60106-9. Review.

15.

Arenavirus variations due to host-specific adaptation.

Zapata JC, Salvato MS.

Viruses. 2013 Jan 17;5(1):241-78. doi: 10.3390/v5010241. Review.

16.

Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children.

Sturdevant CB, Dow A, Jabara CB, Joseph SB, Schnell G, Takamune N, Mallewa M, Heyderman RS, Van Rie A, Swanstrom R.

PLoS Pathog. 2012 Dec;8(12):e1003094. doi: 10.1371/journal.ppat.1003094.

17.

A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.

Holman AG, Gabuzda D.

PLoS One. 2012;7(11):e49538. doi: 10.1371/journal.pone.0049538.

18.

HIV-1 pathogenesis: the virus.

Swanstrom R, Coffin J.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a007443. doi: 10.1101/cshperspect.a007443.

19.

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host.

Brown RJ, Hudson N, Wilson G, Rehman SU, Jabbari S, Hu K, Tarr AW, Borrow P, Joyce M, Lewis J, Zhu LF, Law M, Kneteman N, Tyrrell DL, McKeating JA, Ball JK.

J Virol. 2012 Nov;86(22):11956-66. doi: 10.1128/JVI.01079-12.

20.

HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.

Spudich S, González-Scarano F.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007120. doi: 10.1101/cshperspect.a007120. Review.

Supplemental Content

Support Center